---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-019196"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2026-06-02T21:30:08+00:00"
generated_at: "2026-06-02T21:32:08.349927+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals proposes public offering of common stock; terms not set

## Summary
- Intends to offer common stock in underwritten public offering; no size or price disclosed.
- Underwriter granted 30-day option to purchase up to 15% additional shares on same terms.
- BTIG is lead bookrunner; Lucid Capital Markets joint bookrunner for the offering.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering under effective shelf registration statement (File No. 333-288205) declared effective Dec 22, 2025.

## SEC filing metadata
- accession: 0001437749-26-019196
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2026-06-02T21:30:08+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-019196
- JSON: https://secwatch.observer/filing/0001437749-26-019196.json
- Plain text: https://secwatch.observer/filing/0001437749-26-019196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.